Patient Reported Receipt of Medication Instructions for Warfarin is Associated with Reduced Risk of Serious Bleeding Events
Year: 2008
Type: article
Study design: Observational Study
Institution: University of Pennsylvania
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: U.S. Department of Veterans Affairs, Amgen, Bristol-Myers Squibb, Pfizer, AstraZeneca, GlaxoSmithKline, University of Pennsylvania, Health Services Research and Development, National Institutes of Health, Agency for Healthcare Research and Quality, National Institute on Aging, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: Drug-Induced sudden death & ventricular arrhythmia, Clinical Importance of Drug-Drug Interactions, G1796270042, G243530825, G2870338537, Biologic risk factors of clinical digoxin toxicity, Prediction of warfarin dosing using clinical and genetic factors, G4443218670, CKD the metabolic syndrome & cardiovascular illness, Patient Oriented Research in Anticoagulation
OpenAlex ID: W2035834204
